Kayne Anderson Rudnick Investment Management LLC Moderna, Inc. Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $39.9 Billion
- Q2 2024
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 22,373 shares of MRNA stock, worth $1.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,373
Previous 22,876
2.2%
Holding current value
$1.47 Million
Previous $2.44 Million
8.99%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding MRNA
# of Institutions
1,113Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.86 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.6 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.68 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$988 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$475 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $25.7B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...